Watch the latest episode of focusIR Fireside Chats: Why Edinburgh Investment Trust Is Backing Turnaround Stocks for 2026 Growth. View here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksPHC.L Regulatory News (PHC)

  • There is currently no data for PHC

Updated Myconate Release

26 Sep 2006 07:02

Plant Health Care PLC26 September 2006 Embargoed until 7am 26 September 2006 Plant Health Care plc ("PHC" or "the Group") Myconate - 2006 Trial Results continue to impress around the world Plant Health Care (AIM: PHC.L), a leading provider of natural products forplants and soil, is pleased to report the early success of its Myconate testprogramme in 2006. Building upon the impressive results from prior years, theresults of this year's trials to date further validate the effectiveness ofMyconate in increasing yields of many different crops all over the world. PHC's novel Myconate technology helps crops to develop larger root mass bytriggering the colonisation of beneficial micro-organisms called mycorrhizalfungi. With more mycorrhizal fungi at work, each plant can draw more nutrientsand moisture out of the soil. More nutrients make for healthier plants, andsignificantly greater overall yields. The Board believes Myconate could be thekey to changing the face of farming. The safety and ease of application ofMyconate means that management practices need not be over-hauled. The procedureis a straightforward blending process, either tank mixing the Myconate with thefertilizer during planting, or applying the Myconate to the seed beforeplanting. During 2006, Myconate tests are being performed in numerous countries in theAmericas and Europe, in different soil and climate conditions, with the testsconducted on many different crops and using a range of application methods. Theresults for four of the trials harvested so far this year are shown in thefollowing Table. The results from all of our corn and soybean trials will bereported later. CROP: LOCATION % YIELD INCREASE COMMENTS OVER CONTROL ----------------------------------------------------------------------------- Cotton Georgia, USA 6.9 -10.4% Lint yield, 2 rates used Cotton Coahuila, Mexico 28.6% Lint yield Sorghum Tamaulipas, Mexico 47.1% Grain yield Tomatoes Provence, France 13.3% (saleable) Processing tomatoes Our trials continue to generate interest in Myconate among its target marketsprior to commercial rollout. PHC is currently in discussions with several majoragrichemical and seed companies concerning optimal arrangements for thecommercialisation of Myconate in the principal row crops. Other strategies arebeing explored for the smaller acreage crops. John Brady, CEO of Plant Health Care, commented on the results, "The currenttrials on cotton and tomatoes have been exceptional and further tests on avariety of different crops are underway, leading us to believe that Myconatecould be more widely accepted than previously believed. "We are very excited about the progress being made on current round of Myconatetests. These successes have put us ahead of where we expected to be and it bodesvery well for the future. We expect to sign the first licensing agreement with amajor agri-chemical company in 2007, one year ahead of schedule." -ends- For further information please contact: Plant Health Care plcJohn Brady, CEO Tel: 001 603 525 3702 Tavistock Communications Tel: 020 7920 3150Jeremy CareyChristian Taylor-Wilkinson Notes to Editors: About Plant Health Care Plant Health Care plc ("PHC") is a leading provider of natural products forplants and soil. Established in 1995 in Pittsburgh (Pennsylvania) in the UnitedStates, PHC currently has approximately 70 employees and has operations in theUS, Mexico, UK, Spain, and the Netherlands. The Company listed on the AIM marketof the London Stock Exchange in July 2004. Ticker symbol is PHC. PHC's products are aimed at the landscape, agriculture and land reclamationindustries and are both environmentally beneficial and on the whole more costeffective than synthetic chemical alternatives. Through the commercialisation ofthese products, PHC is capitalising on current long-term trends toward naturalsystems and biological products for plant care and soil and water management. Web Site: www.planthealthcare.com This information is provided by RNS The company news service from the London Stock Exchange
Date   Source Headline
27th Jan 20214:41 pmRNSSecond Price Monitoring Extn
27th Jan 20214:36 pmRNSPrice Monitoring Extension
25th Jan 20217:00 amRNSTrading Statement
11th Jan 20217:00 amRNSNotice of Trading Statement/Investor Presentation
5th Jan 20213:37 pmRNSBrazil approves PHC279 to Control Soybean Rust
11th Dec 20207:00 amRNSInvestor Presentation
9th Nov 20207:00 amRNSPlant Health Care and Wilbur-Ellis sign Agreement
7th Oct 20207:00 amRNSGrant of Options
6th Oct 20207:00 amRNSNew US PREtec Patents Issued
2nd Oct 20205:48 pmRNSSignificant Shareholder
25th Sep 20207:00 amRNSInvestor Presentation
23rd Sep 20207:00 amRNSInvestor Presentation
15th Sep 20207:00 amRNSInterim Report 30 June 2020
29th Jul 20207:00 amRNSTrading Statement
26th Jun 20204:41 pmRNSSecond Price Monitoring Extn
26th Jun 20204:36 pmRNSPrice Monitoring Extension
25th Jun 20207:00 amRNSGrant of Options
18th Jun 20204:41 pmRNSSecond Price Monitoring Extn
18th Jun 20204:36 pmRNSPrice Monitoring Extension
16th Jun 20207:00 amRNSPHC398 Approved by US EPA: PHC279 submitted to EPA
9th Jun 20207:00 amRNSGrant of options
2nd Jun 202011:13 amRNSResult of AGM
29th May 20207:00 amRNSHolding(s) in Company
27th May 20207:00 amRNSUpdate on PHC279 2019 Field Trials
6th May 20205:12 pmRNSAnnual Report & Accounts and AGM Notice Published
1st May 20203:21 pmRNSDirector/PDMR Shareholding
24th Apr 20207:00 amRNSResults for the year ended 31 December 2019
25th Mar 20207:00 amRNSHolding(s) in Company
23rd Mar 20203:45 pmRNSHolding(s) in Company
19th Mar 20203:09 pmRNSHolding(s) in Company
16th Mar 202011:53 amRNSResults of General Meeting
11th Mar 20207:00 amRNSPHC279 Submitted for Regulatory Approval in Brazil
24th Feb 20209:18 amRNSResults of Placing and Subscription
24th Feb 20207:00 amRNSProposed Placing and Subscription
19th Feb 20207:00 amRNSBlock listing Interim Review
5th Feb 20207:00 amRNSEmploy California Registration
23rd Jan 20207:00 amRNSFirst US patent issues for PREtec peptide products
9th Jan 20207:00 amRNSBrazil Update
20th Dec 20197:00 amRNSHolding(s) in Company
19th Dec 20197:00 amRNSTrading Update
3rd Dec 20196:35 pmRNSHolding(s) in Company
22nd Nov 20192:11 pmRNSHolding(s) in Company
15th Nov 20193:42 pmRNSHolding(s) in Company
15th Nov 20193:36 pmRNSHolding(s) in Company
14th Nov 20193:36 pmRNSHolding(s) in Company
14th Nov 20197:00 amRNSHolding(s) in Company
13th Nov 20194:40 pmRNSHolding(s) in Company
13th Nov 20194:08 pmRNSHolding(s) in Company
13th Nov 20193:59 pmRNSHolding(s) in Company
13th Nov 20193:42 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.